Failure of crizotinib based systemic treatment in ALK positive histiocytosis involving the central nervous system: a case report and literature review
Abstract Background Among the histiocytic disorders, anaplastic lymphoma kinase (ALK)-positive histiocytosis emerged in 2008. As more and more cases of the novel entity are reported, our understanding of it is deepened. However, only a few cases with central nervous system (CNS) involvement have bee...
Saved in:
Main Authors: | Qiang He (Author), Wenjie Zhang (Author), Qiang Li (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2022-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
ALK-Positive Histiocytosis: A Case Report and Literature Review
by: Omar Issa JABER, et al.
Published: (2021) -
ALK-positive histiocytosis of the umbilicus with KIF5B-ALK fusion: A case report and review of the literature
by: Yili Zhu, et al.
Published: (2021) -
ALK-driven tumors and targeted therapy: focus on crizotinib
by: Murga-Zamalloa C, et al.
Published: (2014) -
ALK positive histiocytosis in an adult female with an EML4-ALK RNA fusion
by: Jay Mehta, et al.
Published: (2020) -
Repurposing of the ALK Inhibitor Crizotinib for Acute Leukemia and Multiple Myeloma Cells
by: Joelle C. Boulos, et al.
Published: (2021)